Press Releases Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Delayed Deutsche Boerse AG Other stock markets 07:00:18 03/07/2024 BST			5-day change	1st Jan Change
0.81 ^EUR	+7.28%		+1.89%	-25.00%

05-28	Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq	MT
05-28	Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice	05-28	AQ
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates	05-20	AQ
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel	05-16	AQ
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	04-01	AQ
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	03-13	AQ
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	11-30	AQ
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	11-28	AQ
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	11-20	PU
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	11-09	AQ
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30/08/23	AQ
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10/08/23	AQ
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21/06/23	PU
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14/06/23	PU
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06/06/23	AQ
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update	12/05/23	AQ
Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference	20/03/23	AQ
Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments	10/03/23	AQ
Sol Gel Technologies : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K	01/03/23	PU
Sol Gel Technologies : Gel Corporate Presentation	02/02/23	PU
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings	30/01/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Press Releases

Filters